Picture of Advicenne SA logo

ALDVI Advicenne SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Advicenne Updates On Clinical Program In Cystinuria In EU

Feb 18 (Reuters) - Advicenne SA  ADVIC.PA :
    * ADVICENNE PROVIDES AN UPDATE AS ITS OPERATIONS EVOLVE
    * CLINICAL PROGRAM IN CYSTINURIA IN EU IS PROGRESSING. IN
SPITE OF
HURDLES ENCOUNTERED DUE TO ONGOING COVID-19 CRISIS, SUBMISSION
FOR MARKETING AUTHORIZATION IS EXPECTED BY LATE 2022
    * THANKS TO THE POSITIVE EVOLUTION OF THE COMPANY A NUMBER
OF
FINANCING OPTIONS ARE NOW OPEN TO SECURE THE DEVELOPMENT OF THE
COMPANY IN THE MID TERM

Source text for Eikon:  ID:nBw9Q8rHTa 
Further company coverage:  ADVIC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Advicenne SA

See all news